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Abstract 
Vitamin B12 is an essential vitamin that is widely used in medical and food industries. Vitamin B12 biosynthesis is con-
fined to few bacteria and archaea, and as such its production relies on microbial fermentation. Rational strain engi-
neering is dependent on efficient genetic tools and a detailed knowledge of metabolic pathways, regulation of which 
can be applied to improve product yield. Recent advances in synthetic biology and metabolic engineering have been 
used to efficiently construct many microbial chemical factories. Many published reviews have probed the vitamin 
B12 biosynthetic pathway. To maximize the potential of microbes for vitamin B12 production, new strategies and tools 
are required. In this review, we provide a comprehensive understanding of advances in the microbial production of 
vitamin B12, with a particular focus on establishing a heterologous host for the vitamin B12 production, as well as on 
strategies and tools that have been applied to increase microbial cobalamin production. Several worthy strategies 
employed for other products are also included.
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Background
Vitamin B12, also known as cyanocobalamin, belongs 
to the cobalamin family of compounds, which are com-
posed of a corrinoid ring and an upper and lower ligand. 
The upper ligand can be adenosine, methyl, hydroxy, or a 
cyano group [1]. Vitamin B12 is synthesized by prokary-
otes and inhibits the development of pernicious anemia 
in animals.
Microbial de novo biosynthesis of vitamin B12 occurs 
through two alternative routes: the aerobic or anaero-
bic pathway, in bacteria and archaea, respectively. Some 
strains can also synthesize cobalamin by absorbing 
corrinoids via a salvage pathway, as shown in Table  1. 
Tetrapyrrole compounds including cobalamin, heme, and 
bacteriochlorophyll, are derived from δ-aminolevulinate 
(ALA) and a complex interdependent and interactional 
relationship exists among these tetrapyrrole compounds 
in numerous bacterial species [2]. To maintain vitamin 
B12 at stable levels, its biosynthesis and transportation 
is regulated by a cobalamin riboswitch in the 5′ untrans-
lated regions (UTR) of the corresponding genes.
Large scale industrial production of vitamin B12 occurs 
via microbial fermentation, predominantly utilizing Pseu-
domonas denitrificans, Propionibacterium shermanii, or 
Sinorhizobium meliloti [7]. However, these strains have 
several shortcomings, such as long fermentation cycles, 
complex and expensive media requirements, and a lack of 
suitable genetic systems for strain engineering. To date, 
most of the research on these producers has focused on 
traditional strategies, such as random mutagenesis and 
fermentation process optimization, with only limited 
research on metabolic engineering. Recently, engineers 
have shifted their attention to Escherichia coli as a plat-
form for vitamin B12 production. E. coli has become a 
well-studied cell factory that has been extensively used 
for the production of various chemicals, such as ter-
penoids, non-natural alcohols, and poly-(lactate-co-
glycolate) [8–10]. Furthermore, metabolic engineering 
and synthetic biology strategies have been extensively 
applied to improve the production of these compounds 
[11, 12]. Escherichia coli synthesizes ALA via the C5 path-
way and has been used as a microbial cell factory to pro-
duce ALA via C4 and C5 pathways [13, 14] and E. coli can 
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also synthesize vitamin B12 via the salvage pathway. The 
closely related Salmonella typhimurium is able to synthe-
size vitamin B12 de novo. Many genes involved in vitamin 
B12 biosynthesis in S. typhimurium have been shown to 
be functional in E. coli [15–17]. Transfer of 20 genes from 
the S. typhimurium cob locus allowed the production of 
vitamin B12 in E. coli [18]. These advantages facilitate the 
de novo production of vitamin B12 in E. coli.
Due to the complexity of the pathway and its meta-
bolic regulation, numerous studies have been performed 
by various groups on the vitamin B12 biosynthesis. This 
review provides an overview of the vitamin B12 bio-
synthesis and its metabolic regulation, along with an 
investigation of several strategies for the development of 
microbial cell factories, including synthetic biology and 
metabolic engineering, among others. Since research on 
the engineering of vitamin B12 producing strains remains 




As mentioned above, cobalamin can be synthesized 
de novo in prokaryotes through two alternative routes 
according to the timing of cobalt insertion and the 
molecular oxygen requirement. These pathways are the 
aerobic pathway, which has been best studied in P. deni-
trificans, and the anaerobic pathway, which has been best 
studied in S. typhimurium, Bacillus megaterium, and 
P. shermanii, [19]. Both routes differ in terms of cobalt 
chelation (via hydrogenobyrinic a, c-diamide with the 
CobNST complex in the aerobic pathway, and via precor-
rin-2 with CbiK in S. typhimurium) and oxygen require-
ments (the aerobic pathway requires oxygen to promote 
ring-contraction, while the anaerobic pathway does not 
require oxygen in this step) (Fig. 1).
Biosynthetic pathways of tetrapyrrole compounds: 
ALA is synthesized by either C4 or C5 pathway and aden-
osylcobalamin is synthesized either via de novo or salvage 
pathways. The enzymes shown in the adenosylcobalamin 
biosynthetic pathway originate from P. denitrificans or S. 
typhimurium, which use either the aerobic pathway or 
anaerobic pathway, respectively.
The first committed precursor of the tetrapyrrole syn-
thesis pathway is ALA. ALA is synthesized by either the 
C4 pathway or the C5 pathway. In the C4 pathway, the 
enzyme ALA synthase from glycine and succinyl-CoA 
catalyzes the formation of ALA. In the C5 pathway, ALA 
is synthesized from glutamate through three enzymatic 
reactions [20]. Two molecules of ALA are condensed to 
form monopyrrole porphobilinogen by porphobilinogen 
synthase and four porphobilinogen molecules are then 
polymerized and cyclized to form uroporphyrinogen 
III. This reaction is catalyzed by the enzymes porpho-
bilinogen deaminase and uroporphyrinogen III synthase. 
Methylation of uroporphyrinogen III at C-2 and C-7 
results in the synthesis of precorrin-2 (which is a com-
mon precursor of cobalamin), siroheme, and coenzyme 
F430 [7, 21]. In P. denitrificans, CobA catalyzes this meth-
ylation step. In S. typhimurium and E. coli, the fusion 
enzyme CysG is shared between siroheme and cobalamin 
synthesis. The N-terminus of CysG has dehydrogenase/
ferrochelatase activity and the C-terminus has uropor-
phyrinogen III methyltransferase activity. In S. cerevisiae, 
MET1p functions as a uroporphyrinogen III methyl-
transferase [22].
Table 1 Cobalamin biosynthetic pathway in microbes
Unidentified pathways are marked with “*”






 Pseudomonas  
dentrificans
Yes Yes [3]










 Salmonella  
typhimurium
Yes Yes [4]




 Escherichia coli No Yes [4]
 Thermotoga sp. RQ2 No No [6]
 Thermotoga  
maritima MSB8
No No [6]






 Thermotoga  
naphthophila
No No [6]
 Thermotoga  
thermarum
No Yes [6]






 Thermosipho  
melanesiensis
Yes Yes [6]
 Thermosipho  
africanus
Yes Yes [6]
 Kosmotoga olearia No Yes [6]
 Mesotoga prima No No [6]
 Petrotoga mobilis No No [6]
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The aerobic and anaerobic pathways diverge at precor-
rin-2 and converge at coby(II)rinic acid a, c-diamide. 
Eight peripheral methylation reactions occur during de 
novo cobalamin biosynthesis, within identical temporal 
and spatial orders in both the aerobic and anaerobic path-
ways. Many of the methyltransferase enzymes involved in 
these reactions show high degrees of sequence similarity 
[23].
Cob(I)yrinic acid a,c-diamide is adenosylated to form 
adenosyl cobyrinic acid a,c-diamide. Cob(I)yrinic acid 
a,c-diamide adenosyltransferase can also adenosylate 
other corrinoids, where at least the a and c positions of 
the carboxyl groups are amidated. Adenosyl cobyrinic 
acid a,c-diamide is subjected to four stepwise amidation 
reactions at carboxyl groups at positions b, d, e, and g 
to yield adenosyl cobyric acid. Two separate methods 
have evolved to attach (R)-1-amino-2-propanol or (R)-
1-amino-2-propanol phosphate at the f position of the 
carboxyl group of adenosyl cobyric acid in the aerobic 
and anaerobic pathways. In the anaerobic pathway, the 
linker between the corrinoid ring and the lower axial 
ligand is phosphorylated prior to attachment of the 
corrinoid ring. The enzyme PduX from S. enterica is 
an l-threonine kinase used in the de novo synthesis of 
coenzyme B12; however, it is not involved in the cobina-
mide salvage pathway [17]. l-threonine O-3-phosphate 
is then decarboxylated to yield (R)-1-amino-2-propanol 
O-2-phosphate via CobD in S. typhimurium LT2 [15]. 
However, in P. denitrificans it is most likely (although 
proof remains to be published), that (R)-1-amino-
2-propanol is directly attached to the corrinoid ring 
via protein α and β. Currently, protein α remains as 
yet unknown and protein β is a complex of CobC and 
CobD. The molecule is then phosphorylated by CobP, 
which is a bifunctional enzyme possessing ATP:AdoCbi 
(adenosylcobinamide) kinase and GTP:AdoCbi-P gua-
nylyltransferase activity [24]. Two additional reac-
tions transfer lower axial ligands onto AdoCbi-GDP, 
thus producing adenosylcobalamin (AdoCbl). There 
are two alternative views of the last step in vitamin 
B12 biosynthesis. One view is that the last reaction in 
the biosynthesis of AdoCbl involves the addition of 
α-ribazole, catalyzed via cobalamine synthase. However, 
in S. typhimurium, α-ribazole 5′-phosphate is added to 
AdoCbi-GDP and thus, the last reaction would be the 
dephosphorylation of AdoCbl 5′-phosphate to AdoCbl, 
catalyzed by an AdoCbl-5-P phosphatase (CobC) [25]. 
The nucleotide loop assembly pathway is the last char-
acterized reaction in the vitamin B12 biosynthesis. 
BluB from S. meliloti is a member of the reduced form 
of nicotinamide-adenine dinucleotide (NADH)/flavin 
mononucleotide (FMN)-dependent nitroreductase fam-
ily, which can convert FMNH2 to DMB (5, 6-dimeth-
ylbenzimidazole) [26, 27]. In the anaerobic bacterium 
E. limosum, 5-aminoimidazole ribotide is converted to 
DMB by enzymes encoded in the bza operon [28] and 
subsequently, CobT can activate a range of lower ligand 
substrates including DMB, which determine cobamide 
diversity [29].
Salvage pathway
The salvage pathway is a cost-effective way (in terms of 
energy) for bacteria and archaea to obtain cobalamin. In 
gram-negative bacteria, exogenous corrinoids are trans-
ported into the cell via an ATP-binding cassette (ABC) 
transport system, consisting of BtuC, BtuD, and BtuF, 
which are membrane permease, ATPase, and periplas-
mic-binding protein components, respectively. BtuB is a 
TonB-dependent transporter located in the outer mem-
brane, delivering corrinoid to the periplasmic corrinoid-
binding protein BtuF. The latter then delivers corrinoid 
to the BtuCD complex located in the inner membrane 
[30]. Archaea also use ABC transporters for corrinoid 
uptake. Archaeal orthologs of the bacterial BtuC, BtuD, 
and BtuF have been found in Halobacterium sp. strain 
NRC-1 [31]. Subsequent to transport through the mem-
brane, cobinamide is adenosylated by ATP:co(I)rrinoid 
adenosyltransferases (ACATs). Three families of ACATs 
exist, namely: CobA, EutT, and PduO [32]. In bacte-
ria, AdoCbi is the substrate for a bifunctional enzyme 
(CobU in S. typhimurium or CobP in P. denitrificans) 
with kinase and guanylyltransferase activities. In archaea, 
the cbiZ gene encodes an amidohydrolase that converts 
AdoCbi to adenosylcobyric acid, which is condensed 
with 1-aminopropanol-O-2-phosphate by an AdoCbi-
P synthase (CbiB) to yield AdoCbi-P. Since the archaeal 
enzyme lacks AdoCbi kinase activity, CobY, which has 
GTP:AdoCbi-P guanylyltransferase activity, is used to 
transfer guanylyl to AdoCbi-P [30, 33]. Identical to the 
de novo pathway, two additional reactions transfer lower 
axial ligands onto AdoCbi-GDP to produce AdoCbl in 
the salvage pathway.
(See figure on previous page.) 
Fig. 1 Biosynthetic pathways of tetrapyrrole compounds. ALA is synthesized by either the C4 or the C5 pathway. Adenosylcobalamin is synthesized 
via the de novo or via salvage pathways. The enzymes shown in the adenosylcobalamin biosynthetic pathway originate from P. denitrificans or S. 
typhimurium, which either use the aerobic pathway or the anaerobic pathway, respectively
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Metabolic regulation of cobalamin synthesis
The relationship between cobalamin, heme, 
and chlorophyll
Photosynthetic bacteria possess all three tetrapyrrole 
compounds including cobalamin, heme, and bacteri-
ochlorophyll (Fig. 1), which share the same biosynthetic 
pathway from ALA to uroporphyrinogen III. Excess heme 
inhibits HemA via feedback inhibition, reducing the flux 
of cobalamin and bacteriochlorophyll, while heme limita-
tion weakly regulates hemCD, hemH, and hemA expres-
sion in E. coli [34]. However, not just a competitive 
relationship exists among the tetrapyrrole compounds, 
as these compounds also share a complex interdepend-
ent and interactional relationship [2]. Hydrogenobyrinic 
acid synthase from Rhodobacter capsulatus possesses 
two Fe-S centers, a flavin and a heme group [35]. Rhodo-
bacter capsulatus requires a cobalamin cofactor to form 
the isocyclic ring of chlorophyll [36]. Synthesis of heme 
is also cobalamin dependent, as heme synthesis requires 
S-adenosylmethionine as a methyl group donor, while 
S-adenosylmethionine synthesis involves a cobalamin-
dependent enzyme [37]. This complex relationship is 
also manifest at the transcriptional level. E.g., cobalamin 
participates in the regulation of bacteriochlorophyll syn-
thesis via the AerR-CrtJ regulatory pair in R. capsulatus. 
CrtJ is responsible for the repression of bacteriochloro-
phyll during aerobic growth [38], while AerR functions 
as an anti-repressor of CrtJ, inhibiting CrtJ binding to 
the bchC promoter when cobalamin is bound to the con-
served histidine (His145) of AerR [39]. In R. sphaeroides, 
heme affects the ability of PpsR to regulate genes that are 
involved in the tetrapyrrole biosynthesis by binding PpsR 
and changing its DNA binding pattern. Thus, PpsR func-
tions as both a redox and a heme sensor to coordinate 
cellular heme and bacteriochlorophyll levels [38]. This 
complex relationship between tetrapyrrole compounds is 
a consequence of natural evolution.
Regulation of the key enzyme S‑Adenosyl‑l‑methionine: 
uroporphyrinogen III methyltransferase (SUMT)
Feedback inhibition of a key enzyme located at the 
branch point of a biosynthetic pathway is a common 
method for metabolic regulation in microbes. In many 
microorganisms, SUMT regulates cobalamin flux. In P. 
denitrificans, SUMT is sensitive to feedback inhibition by 
cobalamin and corrinoid intermediates, and exhibits sub-
strate inhibition at uroporphyrinogen III concentrations 
above 2  µM [40]. Bacillus megaterium SUMT exhibits 
substrate inhibition at uroporphyrinogen concentrations 
above 0.5 µM [41], while P. denitrificans SUMT is inhib-
ited by uroporphyrinogen concentrations above 0.2  µM 
[40]. Fortunately, uroporphyrinogen III methyltrans-
ferase shows limited substrate inhibition. As an example, 
the uroporphyrinogen III methyltransferase of Methano-
bacterium ivanovii and Paracoccus pantotrophus were 
not inhibited by uroporphyrinogen III, even at concen-
trations of up to 20 µM [42, 43]. The identification of new 
SUMT enzymes that are insensitive to feedback inhibi-
tion to replace the native enzyme of industrial strains 
may be an effective method to improve vitamin B12 yield.
Cobalamin riboswitches
The cobalamin riboswitch is the predominant form of 
metabolic regulation to control vitamin B12 concen-
tration in microbes. Riboswitches are evolutionarily 
conserved non-coding regions that are situated in the 
5′-untranslated region of mRNAs that regulate gene 
expression in response to direct binding of intracellu-
lar metabolites by the RNA itself [44]. Riboswitches are 
composed of two functional domains: one domain serves 
as an evolutionarily conserved natural aptamer, bind-
ing the target metabolite with high selectivity and affin-
ity, while the other domain harnesses allosteric changes 
in RNA structure, caused by aptamer-ligand complex 
formation, to control expression of an adjacent gene or 
operon. Johnson et al. solved the crystal structures of two 
different classes of cobalamin riboswitches, which share a 
common four-way junction (P3–P6 helices), forming the 
core receptor domain that is responsible for cobalamin 
binding, but use distinct peripheral extensions (P8–P11) 
to recognize different cobalamin derivatives [45]. The P6 
extension is present for the AdoCbl binding class, while 
it is absent for the methylcobalamin and the aquoco-
balamin binding classes [45–47]. A kissing-loop interac-
tion between loop L5 of the cobalamin-binding core and 
L13 of the regulatory domain regulates the expression 
machinery [46]. Holmstrom et  al. identified the confor-
mational mechanism responsible for the regulation of 
gene expression by a hydroxocobalamin binding ribos-
witch (env8HyCbl). The authors utilized single-molecule 
fluorescence resonance energy transfer techniques [48]. 
Binding of hydroxocobalamin promotes the formation 
of the L5–L13 kissing-loop, which sequesters the Shine-
Dalgarno sequence via base pairing, thus preventing 
translation initiation. Cobalamin riboswitches participate 
in the regulation of cobalamin biosynthesis and trans-
port at the transcriptional or translational levels, such as 
the btuB gene of E. coli and the cob operon of S. typh-
imurium [49]. In case of transcription inhibition and for 
high cobalamin concentrations, an alternative Rho-inde-
pendent termination hairpin or Rho binding site cause 
premature transcriptional termination. High cobalamin 
concentrations can also promote sequestration of ribo-
some binding sites (RBS) and blockage of translation 
initiation. When cobalamin concentrations are low, an 
anti-terminator hairpin forms, enabling RNA polymerase 
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to complete transcription of the downstream gene. Low 
cobalamin concentrations facilitate anti-sequester hair-
pin formation that releases the RBS, thus enabling trans-
lation initiation [50, 51]. Cobalamin riboswitches also 
have a particular function in ethanolamine utilization. In 
Listeria monocytogenes, a cobalamin riboswitch controls 
the expression of a noncoding regulatory RNA named 
Rli55, which controls the expression of the eut genes that 
requires vitamin B12 as a cofactor and determines ethan-
olamine utilization [52].
Synthetic biology to improve cobalamin 
production
Design of a heterologous biosynthetic pathway for the 
vitamin B12 production
Apart from altering native microbial hosts or identifying 
novel microbial hosts to produce cobalamin, the con-
struction of heterologous biosynthetic pathways in model 
organisms that can be easily genetically manipulated is a 
promising strategy. Synthetic biology is an efficient tool 
that can be used to reconstruct pathways or genetic net-
works to produce compounds in a heterologous host. 
The construction of a vitamin B12 biosynthetic pathway 
in a heterologous host includes selection of a suitable 
host, building the biosynthetic pathway with functional 
components, and pathway tuning (Fig. 2). Several points 
should be noted in the selection of an ideal host. (1) The 
host should have the ability to supply precursors (e.g. 
ALA) and cofactors (e.g. S-adenosylmethionine) for the 
production of the desired chemical. E.g., the heterolo-
gous C4 pathway in E. coli has been reported to generate 
high ALA production [13], avoiding addition of exog-
enous ALA to the medium; (2) there need to be suffi-
cient genetic engineering tools such as transformation 
protocols, expression vectors, and chromosomal gene 
knockout/integration systems to manipulate the host 
[53]; (3) the host is suitable for industrial-scale fermenta-
tion, utilizing cheap and readily available carbon sources 
such as glucose, xylose, and arabinose. When the host 
is selected, various candidate genes from diverse native 
vitamin B12 producers can be expressed in the host. The 
use of in vitro kinetic analysis is an efficient approach to 
detect ideal enzymes. Most of the intermediates of the 
vitamin B12 synthetic pathway are not available; conse-
quently, to prepare substrates for in  vitro kinetic analy-
sis, the desired chemicals need to be separated from the 
products of corresponding strains or be prepared enzy-
matically. The products of an in  vitro assay can then be 
detected by spectroscopic analysis, mass spectrometry, or 
microbiological assays. Sometimes, the heterologous pro-
duction of enzymes does not work and it is necessary to 
screen for novel enzymes from various sources. For heter-
ologous expression studies, all native forms of regulation, 
such as riboswitches, should be removed. After the addi-
tion of transcriptional and translational elements, such 
as promoters, ribosome binding sequences, and termina-
tors, the structural genes for cobalamin synthesis can be 
expressed either monocistronically or polycistronically 
on plasmids or be integrated into the genome. The rapid 
development of synthetic biology tools has facilitated the 
simplified construction of heterologous pathways. Het-
erogeneous genes can be assembled by a number of dif-
ferent techniques such as SLIC, CPEC, Gibson assembly, 
golden gate cloning, DNA assembler, and LCR [54]. When 
too many heterogeneous genes need to be transferred to 
a heterologous host, it is difficult to build the metabolic 
pathway one gene at a time. The metabolic route can be 
split into multiple modules. After sequential validation of 
the function of these modules, their assembly becomes 
possible. The final construct can then be transferred to the 
chosen host for heterologous expression, thus allowing 
the host to synthesize cobalamin. To evaluate the capacity 
of vitamin B12 production, the engineered strains are then 
cultured under optimal conditions.
Design of a heterologous biosynthetic pathway. (A) A 
host for the heterologous biosynthetic pathway is selected 
considering capabilities of precursor and cofactor supply, 
genetic engineering tools, and industrial-scale fermenta-
tion capability using cheap and readily available carbon 
sources. (B) Enzyme activity is verified in vitro and there-
after in  vivo. Products of in  vitro assay or intracellular 
reaction products are detected via spectroscopic analy-
sis, mass spectrometry, or microbiological assays. (C) 
Heterogeneous genes and other functional elements are 
assembled on plasmids via gene assembly methods such 
as SLIC, CPEC, Gibson, golden gate, DNA assembler, 
and LCR, or integrated into the genome. To decrease the 
difficulty of building the metabolic pathway, it is divided 
into separate modules. These modules are sequentially 
verified in a heterologous host, and then assembled. (D) 
Based on the quantification of metabolites, bottlenecks 
should be removed and metabolic flux to target com-
pound maximization. To optimize gene expression in 
the metabolic pathway, promoters, RBS, and gene copy 
number are designed and implemented at the transcrip-
tional or translational levels. (E) The characteristics of 
engineered strains are verified via fermentation. Various 
substrates (e.g., ALA, cobalt ions, betaine and DMB) and 
varying conditions (e.g., dissolved oxygen concentration, 
pH, and temperature) can be optimized to improve yield 
and productivity.
Pathway tuning
Biologists face the challenge to direct the flux of interme-
diates to generate the desired product. To avoid the accu-
mulation of toxic intermediates and to drive flux to the 
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Fig. 2 Design of a heterologous biosynthetic pathway. a A host for the heterologous biosynthetic pathway is selected considering the capability of 
precursor and cofactor supply, genetic engineering tools, and industrial-scale fermentation capability, utilizing cheap and readily available carbon 
sources. b Enzyme activity is verified in vitro and subsequently in vivo. Products of the in vitro assay or intracellular reaction products are detected 
via spectroscopic analysis, mass spectrometry, or microbiological assays. c Heterogeneous genes and other functional elements are assembled on 
plasmids via gene assembly methods such as SLIC, CPEC, Gibson, golden gate, DNA assembler and LCR, or integrated into the genome. To decrease 
the difficulty of building the metabolic pathway, it is divided into separate modules. These modules are verified sequentially in a heterologous 
host and then assembled. d Based on the quantification of metabolites, bottlenecks should be removed and metabolic flux should be integrated 
to target compound maximization. To optimize gene expression in the metabolic pathway, promoters, RBS, and gene copy number are designed 
and implemented at the transcriptional or translational levels. e The characteristics of the engineered strains are verified via fermentation. Various 
substrates (e.g., ALA, cobalt ions, betaine and DMB) and varying conditions (e.g., dissolved oxygen concentration, pH, and temperature) can be 
optimized to improve yield and productivity
desired end product, each step in the pathway needs to 
be balanced. In addition, gene overexpression may cause 
an undesirable metabolic burden on the host, and the 
level of gene expression needs to be accurately adjusted 
to coordinate both metabolic flux and cell growth. 
Sometimes chromosomal expression of heterologous 
metabolic pathways can avoid plasmid instability and 
thus reduce the metabolic burden on the cell. Vitamin B12 
biosynthesis is a highly evolved pathway, with more than 
twenty steps, including corrinoid ring construction and 
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peripheral modifications, and the enzymes involved have 
high substrate specificity. Therefore, it is necessary to 
optimize gene expression in existing metabolic pathways.
Gene expression in a given pathway can be altered at 
the level of transcription or translation [55]. Promoter 
strength affects gene expression at the transcriptional 
level, while DNA sequence of the RBS affects gene expres-
sion at the translational level. The “Ribosome binding 
site calculator” and RBSDesigner have been used to pre-
dict and design synthetic RBSs to yield the desired level 
of protein expression in bacteria [56]. The expression of 
multiple genes in synthetic operons can be optimized to 
enhance production levels via engineering of promoters 
[57] and RBSs [58], or via generation of libraries of tuna-
ble intergenic regions [59]. Tuning operon expression can 
be achieved via different plasmid replicons to control gene 
copy number, different promoters to control the rate of 
transcription initiation, and different RBSs for controlling 
the level of translation [60]. Multiplex automated genome 
engineering (MAGE) can be used for genome-scale opti-
mization of gene expression on the chromosome [61].
The translational efficiency of each gene in an operon 
is affected by intergenic sequence regions and involves 
post-transcriptional processes such as transcription ter-
mination, mRNA stability, and translation initiation. 
Therefore, achieving the desired expression level of each 
gene within an operon remains challenging. Pfleger et al. 
generated libraries of tunable intergenic regions, recom-
bining various post-transcriptional control elements to 
optimize the expression of multiple genes in a synthetic 
operon [62]. Tian et  al. also designed synthetic operons 
that utilize translational coupling to achieve the desired 
expression level ratios [63].
Scaffolding is a way to rapidly increase overall pathway 
flux and is complementary to these conventional methods. 
Scaffolding can increase the effective concentration of inter-
mediates in the pathway of interest, via the recruitment of 
enzymes to synthetic protein scaffolds. Three mevalonate 
biosynthetic enzymes (acetoacetyl-CoA thiolase, hydroxy-
methylglutaryl-CoA synthase, and hydroxymethylglutaryl-
CoA reductase) were recruited to a synthetic protein scaffold 
through interactions between the GTPase binding domain, 
the SH3 domain, the PSD95/DlgA/Zo-1 domain and their 
respective ligands, increasing mevalonate yields 77-fold 
compared to cells without the scaffold [64]. Protein scaffolds 
simulate natural multienzyme complexes and have been 
used to solve problems of toxic pathway intermediate accu-
mulation, competing metabolic reactions, and imbalances 
in flux [65]. Protein scaffolds have been successfully applied 
in various other pathways, including the glucaric acid path-
way, where three pathway enzymes were joined in a protein 
scaffold, increasing titers by approximately five-fold [66]. In 
another example, heterologous butyrate pathway enzymes 
were co-localized in a protein scaffold, resulting in a three-
fold improvement in butyrate production [67]. Cobalamin 
synthesis is a complex pathway with several competing 
intermediates, such as heme and siroheme. Co-localization 
of enzymes to the same subcellular organelle or compart-
ment can increase the local intermediate concentration and 
exclude competing cytosolic pathways [68]. Substrate chan-
neling is a process of transferring the product of one enzyme 
to an adjacent enzyme within the cascade or cell without 
complete mixing with the bulk phase [69]. This phenom-
enon occurs for at least some of the enzymes involved in 
hydrogenobyrinic acid (HBA) biosynthesis. An enzyme-trap 
approach has been used to isolate intermediates of the cobal-
amin biosynthetic pathway based on this mechanism [70]. 
Therefore, protein scaffolds may offer a promising alternative 
to balance multiple enzymes within the vitamin B12 biosyn-
thetic pathway, thus improving flux to cobalamin.
All these approaches optimize gene expression or 
increase pathway flux in vivo. In vitro steady-state anal-
ysis is an efficient approach to identify bottlenecks in 
metabolic pathways and to balance flux to the desired 
compounds. It has been successfully used to increase the 
production of fatty acids, fatty acid short-chain esters, 
fatty alcohols, farnesenes, alkenes, and alkanes [71–75]. 
Previously, we have optimized the concentration of 
enzymes involved in precorrin-2 synthesis in  vitro via 
response surface methodology [76]. This approach mini-
mizes the effects of substrate inhibition and feedback 
inhibition by SUMT and increases the production of 
precorrin-2 approximately five-fold.
Construction of a heterologous biosynthetic pathway 
for cobalamin in E. coli
Escherichia coli is a well-characterized prokaryote that 
has been used as a microbial cell factory for many chemi-
cals. Although it has lost the de novo cobalamin synthesis 
pathway during evolution, E. coli can synthesize cobala-
min through the salvage pathway, thus saving resources 
and energy. Escherichia coli has been used to produce 
ALA in many studies. A sufficient ALA supply is neces-
sary for the vitamin B12 biosynthesis. This implies that 
E. coli may be a suitable host for vitamin B12 production. 
Other common bacteria such as Corynebacterium glu-
tamicum and Bacillus subtilis lack the genes involved in 
the cobalamin synthesis pathway after precorrin-2, which 
may explain why the construction of a heterologous de 
novo cobalamin synthesis pathway in bacteria other than 
E. coli has yet to be reported.
For a long time, cobalamin production was restricted to 
native bacterial producers, with the exception of several 
studies that focused on the determination of gene func-
tion in the cobalamin synthesis pathway in  vivo [16, 35, 
70, 77] or by using cell extracts from recombinant E. coli 
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Table 2 Research on the biosynthesis of vitamin B12 and its intermediates in vivo and in vitro in E. coli
Strains Products Strategies References
In vivo
 E. coli Cobyric acid Expression of the cob I operon of B. megaterium and cbiP of S. typhimurium [77]
 E. coli Cobyrinic acid a,c-diamide Co-expression of the cobA gene from P. freudenreichii and the cbiAP, cbiCDETFGHJ, and cbiJKL 
genes from S. typhimurium
[16]
 E. coli HBA Co-expression of cobA, cobI, cobJ, cobF, cobM, cobK, cobL, and cobH from R. capsulatus SB1003, 
and cobG from B. melitensis 16M or P. denitrificans
[70]
 E. coli HBA Co-expression of cobA, cobI, cobJ, cobF, cobM, cobK, cobL, cobE, cobH and cobZ from R. capsulatus [35]
 E. coli Vitamin B12 Expression of the operon pduBAF-pocR-cbiABCDETFGHJKLMNQOP-cobUST from S. typhimurium [18]
 E. coli Vitamin B12 Co-expression of cobWNEMcbtAB, tonBcobOBRDCQchlID and cobGHIJLFK from P. denitrificans [83]
In vitro
 E. coli HBA E. coli native genes hemB, hemC, hemD, and cobA, cobI, cobG, cobJ, cobF, cobM, cobK, cobL, and 
cobH genes from P. denitrificans were heterologously expressed in E. coli. HBA was produced 
when ALA was added to the media and the cells were incubated aerobically in 200 ml Tris–HCl 
buffer, pH 8.0, containing SAM, NADH, and NADPH for 15 h at 30 °C with a mixture of twelve 
enzymes: HemB, HemC, HemD, crude enzyme extract of CobA, CobI, CobG, CobJ, CobM, CobF, 
CobK, CobL, and CobH
[78]
 E. coli Precorrin3b and precorrin-4 The cobG and cobJ genes from P. denitrificans were heterologously expressed in E. coli. Aerobic 
incubation of precorrin-3A with the CobG enzyme from P. denitrificans alone yielded precor-
rin3B. When CobJ from P. denitrificans and S-adenosyl-l-methionine were included in the 
reaction, the product precorrin-4 was formed
[18]
 E. coli Cob(II)yrinic acid a,c-
diamide
The cobN, cobS, and cobT from B. melitensis were expressed and purified from E. coli. In the pres-
ence of ATP, Co2+, and hydrogenobyrinic acid a,c diamide, these enzymes together produced 
cobyrinic acid
[81]
 E. coli Cob(I)yrinic acid a,c-diamide CobR from B. melitensis was expressed and purified from E. coli. This enzmye was confirmed to 
have co(II)rrin reductase activity
[82]
in vitro (Table 2) [78–82]. After insertion of the B. mega-
terium cob I operon and S. typhimurium cbiP, E. coli was 
able to synthesize cobyric acid de novo [77]. Co-expression 
of the cobA gene from Propionibacterium freudenreichii 
and the cbiAP, cbiCDETFGHJ and cbiJKL genes from S. 
typhimurium equipped E. coli with the ability to produce 
cobyrinic acid a,c-diamide [16]. Apart from the genes 
involved in the anaerobic cobalamin biosynthetic pathway, 
genes involved in aerobic cobalamin biosynthetic pathway 
have also been shown to work in E. coli. Furthermore, E. 
coli possesses enzymes that perform the transformation 
of uroporphyrinogen III into HBA, thus potentially pro-
ducing HBA [70]. McGoldrick et  al. conducted a similar 
experiment, where nine genes from R. capsulatus and Bru-
cella melitensis, encoding enzymes for the transformation 
of uroporphyrinogen III into HBA, were constructed as an 
operon in pET14b and introduced into E. coli, allowing the 
host to produce HBA [35]. To the best of our knowledge, 
there are only two reports on de novo cobalamin synthe-
sis in E. coli: Firstly, an E. coli strain harboring a plasmid 
with a 21.5-kb native operon (pduBAF-pocR-cbiABCDET-
FGHJKLMNQOP-cobUST) from S. typhimurium resulted 
in de novo cobalamin biosynthesis [18]. Recently, Ko et al. 
also accomplished cobalamin biosynthesis in E. coli [83]. 
Twenty-two genes located in six different operons of P. 
denitrificans were cloned via traditional restriction and 
ligation into three compatible plasmids under the control 
of a T7 promoter. The recombinant E. coli strain harbor-
ing these three plasmids produced vitamin B12 under 
both anaerobic and aerobic conditions. Via optimizing 
the culture conditions, the engineered strain produced 
0.65  ±  0.03  μg/g cdw of coenzyme B12. These examples 
show that E. coli can be utilized to produce vitamin B12 
or pathway intermediates de novo through the aerobic or 
anaerobic pathway.
Metabolic engineering for cobalamin production
Scheme of metabolic engineering
When a micro-organism possesses its own or a heter-
ologous cobalamin synthesis pathway, efforts should 
be directed towards engineering the metabolic network 
to enhance vitamin B12 production and yield. Classi-
cal metabolic engineering involves an iterative process 
of synthesis and analysis, where increasingly refined 
strains are designed and constructed based on gathered 
knowledge [84]. However, systems metabolic engineering 
allows microbes to be engineered at the whole-organism 
level for the production of valuable chemicals far beyond 
their native capabilities [85]. Metabolic design based on 
in silico simulations and experimental validation of the 
metabolic state in the engineered strain facilitates sys-
tematic metabolic engineering [86]. Many genome-scale 
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metabolic flux models have been developed to design 
microbial cell factories. In silico simulations based on 
genome-scale metabolic models have provided valid 
guidance for rational design. Computational tools used 
in metabolic flux analysis and gene manipulation stud-
ies have been systematically reviewed [87]. Depending on 
the design of the specific strain, experimental implemen-
tation can involve a combination of gene over-expres-
sion, introduction of foreign enzymes, gene deletions, or 
knockdowns and the modification of enzyme properties.
Gene over‑expression and heterologous expression
Gene over-expression is used to enhance or redirect 
flux to the desired chemical reaction. Expression of the 
target gene can be increased through the use of multi-
copy plasmids, or the insertion of transcriptional and 
translational control elements, such as strong promot-
ers, highly efficient RBSs, and terminator sequences. 
The introduction of heterologous genes is used to over-
come the comparatively low activity of native genes 
in a host. The structural genes required for cobalamin 
synthesis are typically targets for gene over-expression 
to boost cobalamin production. In a recombinant P. 
freudenreichii strain, which harbors an expression vector 
containing cobA, cbiLF, or cbiEGH, vitamin B12 produc-
tion was increased 1.7-, 1.9-, and 1.5-fold, respectively, 
compared to P. freudenreichii harboring the expression 
vector pPK705 [88]. Expression of cobU and cobS in 
the same P. freudenreichii strain led to a slight increase 
in the production of vitamin B12. ALA is a precursor, 
restricting cobalamin synthesis and a direct strategy 
to overcome this is to up-regulate the availability of 
ALA. A recombinant P. freudenreichii strain with het-
erologous hemA from R. sphaeroides, hemB, and cobA 
homologues, revealed a 2.2-fold increase in vitamin B12 
production [88]. To improve the production of tetrapy-
rrole compounds, the hemA gene from R. sphaeroides 
and the hemB gene from P. freudenreichii subsp. sherma-
nii IFO12424 were expressed either monocistronically 
or polycistronically in the strain P. freudenreichii subsp. 
shermanii IFO12426. The recombinant strains accumu-
lated larger amounts of ALA and PBG, with a resultant 
28- to 33-fold increase in the production of porphy-
rinogens, compared to strain P. freudenreichii subsp. 
shermanii IFO12426, harboring the vector pPK705 
[89]. A cobalamin-riboswitch can be used to inhibit 
excess vitamin B12 in microbes. To bypass the effects 
of the cobalamin-riboswitch, a cbi operon without the 
cobalamin-riboswitch was cloned. Growth of B. megate-
rium, harboring a plasmid expressing the cbi operon on 
minimal media supplemented with glycerol as a carbon 
source, resulted in a significant increase in cobalamin 
production (up to 200  μg/l) [90]. All these strategies 
focus on the over-expression of structural genes that are 
directly involved in the vitamin B12 biosynthesis. How-
ever, to the best of our knowledge, no published reports 
exist on other genes, such as those responsible for the 
S-adenosylmethionine (SAM) or DMB metabolism. This 
suggests that research into the metabolic engineering of 
vitamin B12 production is still in its infancy.
Inactivation or down‑regulation of genes
A further general method of metabolic engineering is 
to knockout genes to improve precursor supply, or to 
eliminate by-products or competing chemical synthesis 
reactions. Genes that encode enzymes at specific branch 
points in the metabolic pathway are good targets for this 
strategy. For essential genes that cannot be deleted, clus-
tered regularly interspaced short palindromic repeats 
(CRISPR), CRISPR interference (CRISPRi), sRNA, or 
regulatory RNA can be used to repress the desired genes 
[91, 92]. Many genome editing tools such as, traditional 
homologous recombination systems and ZFN (zinc fin-
ger nucleases), TALEN (transcription activator-like effec-
tor nucleases), and CRISPR/Cas-based methods readily 
enable genetic modifications. Heme and siroheme are 
competitive byproducts of the vitamin B12 synthesis. To 
reduce flux to the heme branch of the tetrapyrrole path-
way, antisense RNA was used to silence hemZ (which 
encodes coproporphyrinogen III oxidase) in B. megate-
rium. This approach led to a 20% increase in the intra-
cellular vitamin B12 concentration [93]. We also inhibited 
hemE and hemH to improve flux to precorrin-2 via an 
sRNA approach (unpublished data).
Protein engineering
During the engineering of native or heterologous hosts to 
produce a desired chemical, a common scenario is that 
a substance or product inhibits an enzyme or it may not 
function heterologously. Protein engineering is a useful 
approach to improve the specificity, solubility, and sta-
bility of enzymes. It includes directed evolution, semi 
rational design, and rational design. The enzyme gluta-
myl-tRNA reductase (HemA) catalyzes the first commit-
ted step in the heme biosynthetic pathway. Expression 
of this gene is inhibited in a negative feedback loop by 
excess heme. The addition of two positively charged 
lysine residues to the third and fourth positions of the N 
terminus of HemA resulted in a complete stabilization of 
the protein. Cells expressing the stabilized HemA showed 
a substantial decrease in heme inhibition [94]. Engineer-
ing of CobA to remove substrate inhibition or the identi-
fication of novel genes without substrate inhibition may 
improve the yield of vitamin B12.
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13C‑metabolic flux analysis
13C-metabolic flux analysis is an efficient method to 
determine flux distribution based on experimental data 
and has been used to accurately estimate flux in the cen-
tral carbon metabolism of P. denitrificans in response to 
different specific oxygen uptake rates under oxygen limit-
ing conditions [95]. Metabolic flux analysis revealed that 
glucose was predominantly catabolized by the Entner–
Doudoroff and pentose phosphate pathways. A higher 
specific oxygen uptake rate accelerated the supply of pre-
cursors, methyl groups, and NADPH to increase vitamin 
B12 production [95].
Other strategies to improve cobalamin production
Random mutagenesis
To produce strains with a high cobalamin yield, a con-
ventional strategy is random mutagenesis. Specifically, 
UV light or chemical mutagens can both be used to 
treat the respective microorganisms and then, strains 
with the desired phenotype, such as improved pro-
ductivity, genetic stability, reasonable growth rates, or 
resistance to high concentrations of toxic intermediates 
can be selected [7]. High throughput screening meth-
ods based on signals, such as survival and fluorescence, 
have been used to obtain desired mutants from large 
libraries. Moreover, random mutagenesis can also be 
applied to inverse metabolic engineering for targeted 
transformation.
Genome‑scale engineering
Genome shuffling, an approach that combines ran-
dom mutagenesis and protoplast fusion, has been used 
to improve vitamin B12 production in P. shermanii. The 
engineered P. shermanii strain produced approximately 
61% more vitamin B12 than the parent strain after 96 h. 
Comparative proteome analysis revealed that the expres-
sion of 38 proteins varied significantly [96]. Compared 
to genome shuffling, which results in random muta-
tions, MAGE provides an efficient method to simulta-
neously modify multiple genomic locations [61]. MAGE 
is based on the λ red recombination system. The repeti-
tive introduction of ssDNA targeting multiple loci in the 
E. coli genome results in various mutants. Combined 
with standard high-throughput screening methods, 
MAGE may represent a rapid and efficient tool to obtain 
“ideal” bacterial producers. In addition, another versatile 
method, trackable multiplex recombineering (TRMR), 
enables rapid and simultaneous modification and map-
ping of thousands of genes. By changing functional 
regions such as promoters, translation sites, switches, 
oscillators, or sensors, a broad range of studies can be 
performed [97].
Biosensors
Biosensors have been extensively applied in high-
throughput assays. For chemicals that cannot be easily 
detected via measurement of absorption or fluorescence, 
biosensors indirectly reflect chemical concentrations. 
A vitamin B12 riboswitch sensor has been used to study 
synthesis and import of coenzyme B12, and was shown 
to detect intracellular vitamin B12 concentration using 
colorimetric, fluorescent, or luminescent reporters with 
high sensitivity [98]. Reporter genes integrated with the 
btuB riboswitch have been used to monitor intracellular 
AdoCbl concentrations [98]. A combination of evolu-
tionary strategies applied to metabolic pathways, whole 
genomes, or biosensors may be a useful approach to 
advance high-throughput screening for “ideal” strains.
Fermentation process optimization
The addition of precursors of the vitamin B12 biosyn-
thetic pathway, such as cobalt ions, ALA, DMB, glycine, 
threonine, or compatible solutes like betaine and choline 
has been frequently described to be beneficial [7]. Pro-
pionic acid is a byproduct of the vitamin B12 cultivation 
process in P. freudenreichii and causes feedback inhibi-
tion of microbial cell growth. Propionic acid production 
and DMB addition were controlled via expanded bed 
adsorption bioreactors, which were shown to improve 
vitamin B12 biosynthesis [99]. Mixed culture of Propioni-
bacterium and Ralstonia eutropha have also been used to 
solve this problem, as the latter can assimilate propionic 
acid produced by the former [100]. Betaine is an impor-
tant methyl-group donor for the formation of methio-
nine, which is further converted to SAM by the activity of 
methionine adenosyltransferase. S-adenosylmethionine 
is an important precursor during corrinoid ring forma-
tion. Despite the fact that betaine delays cell growth, 
betaine feeding during fermentation has been revealed as 
an effective strategy to increase vitamin B12 production 
[101]. To reduce medium and fermentation costs, cheap 
carbon sources such as maltose syrup and corn steep liq-
uor can be used to replace refined sucrose [102].
Conclusions
Vitamin B12 is widely used in medical and food indus-
tries and microbes produce vitamin B12 via an intricate 
pathway. Tetrapyrrole compounds, including heme, 
cobalamin, and siroheme are not simple competitive 
compounds, but have both interdependent and interac-
tive relationships in several bacterial species. To main-
tain stable vitamin B12 concentrations, its biosynthesis 
and transport are regulated at the transcriptional or 
translational level via riboswitches. Vitamin B12 is pro-
duced by microbial fermentation, using strains such as 
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P. denitrificans and P. shermanii. Since relatively few 
genetic tools are available for these strains, and the fer-
mentation process is complicated, strain engineering 
has focused on traditional strategies such as random 
mutagenesis and the optimization of the fermentation 
process. It is imperative to introduce new engineer-
ing tools, such as systems metabolic engineering, to 
manipulate these strains. Apart from native producers 
of vitamin B12, E. coli has also been used as a heterolo-
gous host. To provide guidance for the construction of 
microbial cell factories for vitamin B12 production, we 
summarized synthetic biology and metabolic engineer-
ing strategies, as well as other traditional strategies that 
either have been or could be applied to vitamin B12 pro-
duction. These strategies have been extensively applied 
in microbial strain engineering to improve the produc-
tion of many other chemicals. Based on a clear under-
standing of the vitamin B12 metabolism in microbes, 
the utilization of these strategies should promote an 
improved microbial vitamin B12 production.
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